Abstract
Introduction
Quetiapine, a second-generation antipsychotic, acts at multiple brain neurotransmitter receptors and has the potential for serious complications. Although seizures have been described in the literature, delayed seizure onset has not been reported. We report the first case of delayed seizures after a significant quetiapine overdose.
Case Report
A 27-year-old female presented to the emergency department following an overdose of approximately 30 g of quetiapine. Twenty-four hours after arrival, the patient had 2 seizures. The patient was then intubated and remained in the ICU for four days. EEG was negative for epileptiform activity. The serum quetiapine levels (MedTox, St. Paul, MN) were 8.67 mg/L on hospital day one and 3.28 mg/L on hospital day three.
Discussion
Quetiapine poisoning, with serum levels, associated with seizures has been reported in one prior case. Our case report represents late-onset seizures with serum levels above therapeutic range (> 1 mg/L). The serum concentrations of quetiapine in this case were consistent with those in postmortem case reports.
Keywords: quetiapine, overdose, seizure, serum level
Full Text
The Full Text of this article is available as a PDF (109.2 KB).
Footnotes
There was no outside funding of any kind used for this study.
References
- 1.Balit CR, Isbister GK, Hackett PL, Whyte IM. Quetiapine poisoning: a case series. Ann of Emerg Med. 2003;42:751–758. doi: 10.1016/S0196-0644(03)00600-0. [DOI] [PubMed] [Google Scholar]
- 2.Strachan PM, Benoff BA. Mental status change, myoclonus, electrocardiographic changes, and acute respiratory distress syndrome induced by quetiapine overdose. Pharmacotherapy. 2006;26(4):578–582. doi: 10.1592/phco.26.4.578. [DOI] [PubMed] [Google Scholar]
- 3.Langman LL, Kaliciak HA, Carlyle S. Case report: fatal overdoses associated with quetiapine.J Anal Toxicol 2004;28. [DOI] [PubMed]
- 4.Flammia DD, Valouch T, Venuti S. Case report: tissue distribution of quetiapine in 20 cases in Virginia. J Anal Toxicol. 2006;30:287–292. doi: 10.1093/jat/30.4.287. [DOI] [PubMed] [Google Scholar]
- 5.Hopenwasser J, Mozayani A, Danielson T, et al. Postmortem distribution of the novel antipsychotic drug quetiapine. J Anal Toxicol. 2004;28:264–268. doi: 10.1093/jat/28.4.264. [DOI] [PubMed] [Google Scholar]
- 6.Hedges D, Jeppson K, Whitehead P. Antipsychotic medication and seizures: a review. Drugs Today (Barc) 2003;39:551–557. doi: 10.1358/dot.2003.39.7.799445. [DOI] [PubMed] [Google Scholar]
- 7.Quetiapine (Seroquel®) Package Insert. AstraZeneca Pharmaceuticals, October 2006.
- 8.Centorrino F, Price BH, Tuttle M, et al. EEG abnormalities during treatment with typical and atypical antipsychotics. Am J Psychiatry. 2002;159:109–115. doi: 10.1176/appi.ajp.159.1.109. [DOI] [PubMed] [Google Scholar]
- 9.Amann BL, Pogarell O, Mergl R, et al. EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects. Hum Psychopharmacol. 2003;18:641–646. doi: 10.1002/hup.537. [DOI] [PubMed] [Google Scholar]
- 10.Mauri MC, Volonteri LS, Colasanti A, et al. Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response. Clin Pharmacokinet. 2007;46:359–388. doi: 10.2165/00003088-200746050-00001. [DOI] [PubMed] [Google Scholar]
- 11.Rodda KE, Drummer OH. The redistribution of selected psychiatric drugs in post-mortem cases. Forensic Sci Int. 2006;164:235–239. doi: 10.1016/j.forsciint.2006.02.013. [DOI] [PubMed] [Google Scholar]
- 12.Parker DR, McIntyre IM. Case studies of postmortem quetiapine: therapeutic or toxic concentrations? J Anal Toxicol. 2005;29:407–412. doi: 10.1093/jat/29.5.407. [DOI] [PubMed] [Google Scholar]